Interaction of the D1Receptor Antagonist Sch 23390 with the Central 5-HT System: Radioligang Binding Studies, Measurements of Biochemical Parameters and Effects on L-5-HTP Syndrome-Reference-Cited by-同舟云学术

Interaction of the D1Receptor Antagonist Sch 23390 with the Central 5-HT System: Radioligang Binding Studies, Measurements of Biochemical Parameters and Effects on L-5-HTP Syndrome

Published:1988-01 Issue:1-4 Volume:8 Page:107-120
ISSN:0197-5110
Container-title:Journal of Receptor Research
language:en
Short-container-title:Journal of Receptor Research

Author:

Bischoff S.,Heinrich M.,Krauss J.,Sills M. A.,Williams M.,Vassout A.

Publisher

Informa UK Limited

Subject

Pharmacology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10799898809048981

Reference19 articles.

1. 5HT-receptor antagonist properties of SCH 23390 in vascular smooth muscle and brain

2. Pharmacological effects of a specific dopamine D-1 antagonist SCH 23390 in comparison with neuroleptics

3. 5-HT1A-receptors mediate stimulation of adenylate cyclase in rat hippocampus

4. The D-1 dopamine receptor antagonist SCH 23390 also interacts potently with brain serotonin (5-HT2) receptors

Cited by 39 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. 6-Hydroxydopamine Lesioning of Dopamine Neurons in Neonatal and Adult Rats Induces Age-Dependent Consequences;Handbook of Neurotoxicity;2022

2. A dynamic role for dopamine receptors in the control of mammalian spinal networks;Scientific Reports;2020-10-02

3. D1 receptors in the anterior cingulate cortex modulate basal mechanical sensitivity threshold and glutamatergic synaptic transmission;Molecular Brain;2020-09-05

4. Advances in Dopamine D1 Receptor Ligands for Neurotherapeutics;Current Topics in Medicinal Chemistry;2019-09-16

5. Neuroleptic malignant syndrome and serotonin syndrome;Thermoregulation: From Basic Neuroscience to Clinical Neurology, Part II;2018